Evidence map›Paper›PMID 42511973›Full record

ReviewBiomedicines2026

Pulmonary Complications in Cirrhosis: Current Concepts and Clinical Perspectives.

Sarocha Vivatvakin, Duangporn Werawatganon

Abstract readReview
In one paragraph

Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sarocha VivatvakinCenter of Excellence in Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Duangporn WerawatganonCenter of Excellence in Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0001-8847-9690

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The liver and lungs maintain an essential anatomical and physiological network crucial for systemic homeostasis. In the presence of cirrhosis, particularly when accompanied by portal hypertension, this intricate communication is disrupted. The resulting alterations can lead to a range of pulmonary complications through intertwined vascular, immunologic, and mechanical mechanisms that underscore the close relationship between these two organs. This review provides an overview of the liver-lung axis and summarizes current concepts of the pathophysiological processes by which advanced liver disease contributes to major respiratory complications. It also highlights diagnostic principles and clinical manifestations, with emphasis on hepatopulmonary syndrome, portopulmonary hypertension, and hepatic hydrothorax. Although these conditions differ substantially in their underlying pathogenesis, they share common clinical consequences, including impaired arterial oxygenation, reduced functional capacity, and an increased risk of mortality prior to liver transplantation. In addition, the review explores the ongoing debate regarding the potential association between chronic hepatitis C virus infection and pulmonary fibrosis. Overall, early recognition of these pulmonary complications is crucial, as they have important implications for symptom burden, therapeutic decision-making, liver transplant eligibility, and overall clinical outcomes in patients with chronic liver disease.

Indexed as

cirrhosishepatic hydrothoraxhepatitis C virushepatopulmonary syndromeidiopathic pulmonary fibrosisliver–lung axisportal hypertensionportopulmonary hypertension

Identifiers

PMID42511973
PMCPMC13405752

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.